R&D investment of over 20 million yuan, a parenteral nutrition preparation of Hengrui Medicine was approved for marketing

  • Post date April 19, 2022 — 14:51 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

002653 China Shipbuilding Industry Group Power Citic Securities Fujian Funeng Haisco Pharmaceutical Group Jiangsu Hengrui Medicine Xinjiang Sayram Modern Agriculture Strategy, Marketing Research, Development Energy, Resource Medicine Therapy

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data